Tizanidine Tablet
Product Images NDC 71335-3016

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-3016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of Tizanidine hydrochloride, showing its molecular framework with chlorine, sulfur, nitrogen atoms, and two ring systems including an imidazoline and a thieno ring.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph showing plasma concentration of Tizanidine (ng/mL) over time (hours) after dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, depicting their concentration-time profiles up to 24 hours post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth Score over time (hours post-dose) comparing 8 mg and 16 mg doses of tizanidine versus placebo. The graph includes error bars for each data point and demonstrates the 16 mg dose having the greatest improvement, followed by 8 mg, and placebo showing minimal change over 6 hours.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line chart depicting improvement in Ashworth Score over time for two groups: tizanidine (mean dose 28.8 mg) and placebo. The x-axis shows time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis measures improvement, with negative values indicating greater improvement. Data points for tizanidine are shown with squares and for placebo with circles, each including error bars.*

FDA Label Image

Label (Lbl713353016)

Label for Tizanidine Tablets USP, 4 mg strength, containing 90 tablets. The label includes NDC 71335-3016-1, BRP Pharmaceuticals logo, and storage instructions. Repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by ALKALOIDA Chemical Company Zrt. Barcode and QR codes for product and package insert are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.